Antipas, Leonardo A.

HRN: 21-53-10  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/14/2022
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
07/14/2022
07/21/2022
IV
1.5g
Q6
Cellulitis, Right Leg
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Bone & JointSkin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: